YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Bristol-Myers to buy MyoKardia for $13B

Posted online

Bristol-Myers Squibb agreed to purchase MyoKardia for roughly $13 billion.

The deal would give Bristol-Meyers access to experimental heart disease therapy mavacamten.

The purchase agreement follows Bristol-Myers' $74 billion acquisition of Celgene last year.

Read more from CNBC.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Annual downtown holiday events combine for Nov. 21 celebration

Organizers hope to bolster client traffic to center city businesses.

Most Read
SBJ.net Poll
How often do you use artificial intelligence for your business?

*

View results

Update cookies preferences